AstraZeneca sales beat forecasts on Covid jab demand

Revenue rises 60% as Alexion acquisition and its rare diseases medicines boost drugmaker’s earnings
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news